Pre−treatment cytokines plus TPSA predict biochemical progression−free survival in prostate cancer metastasis and discriminate metastatic status: a retrospective study
These results underscore the immunological relevance of specific cytokines in PCa progression and their potential as complementary biomarkers to PSA for improving risk stratification.
Authors
- Bo Sun (ORCID: https://orcid.org/0000-0002-3217-0579)
- Zhigang Wu (ORCID: https://orcid.org/0000-0002-0016-430X)
- Chaofeng Zhou
- Jing Sun (ORCID: https://orcid.org/0000-0001-6787-5782)
- Chen Sun (ORCID: https://orcid.org/0000-0002-5145-1536)
- Jian Cai (ORCID: https://orcid.org/0000-0002-2758-2528)
- Kaihao Mao
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3389/fimmu.2025.1686570
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Wenzhou Medical University